KRT19 and neoplasm: Although no studies thus far have shown a correlation between serum tumor marker levels and EGFR mutation status, in vitro studies using hepatocellular carcinoma and head and neck cancer cell lines have shown an EGF-dependent increase in cytokeratin 19 [11, 12].